AVITA MEDICAL INC (RCEL) Stock Earnings Estimates
NASDAQ:RCEL • US05380C1027
5 USD
-0.39 (-7.24%)
At close: Feb 25, 2026
4.99 USD
-0.01 (-0.2%)
After Hours: 2/25/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.42M 17.76% | 50.143M 45.68% | 64.251M 28.14% | 72.681M 13.12% | 87.142M 19.90% | 130.35M 49.58% | 232.57M 78.42% | 294.04M 26.43% | 344.21M 17.06% | 410.7M 19.32% | 486.84M 18.54% | 596.75M 22.58% | |
| EBITDA YoY % growth | -26.56M -3.79% | -41.715M -57.06% | -54.873M -31.54% | -41.31M 24.72% | -22.644M 45.19% | -12.75M 43.69% | 30.793M 341.51% | 37.481M 21.72% | 44.018M 17.44% | 50.146M 13.92% | 56.069M 11.81% | 61.891M 10.38% | |
| EBIT YoY % growth | -27.13M -3.12% | -42.347M -56.09% | -55.999M -32.24% | -43.309M 22.66% | -30.105M 30.49% | 19.693M 165.42% | 105.44M 435.42% | 138.93M 31.76% | 190.12M 36.85% | 259.82M 36.66% | 325.42M 25.25% | 421.09M 29.40% | |
| Operating Margin | -78.82% | -84.45% | -87.16% | -59.59% | -34.55% | 15.11% | 45.34% | 47.25% | 55.23% | 63.26% | 66.84% | 70.56% | |
| EPS YoY % growth | -1.07 8.55% | -1.40 -30.84% | -2.39 -70.71% | -1.53 26.78% | -0.88 49.68% | -0.33 62.55% | 3.33 1,111.20% | 2.83 -15.00% | 3.72 31.17% | 4.87 30.95% | 6.14 26.14% | 7.93 29.10% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 48.68% | -0.28 25.74% | -0.23 49.00% | -0.21 44.53% | -0.19 28.75% | -0.17 38.55% | -0.10 56.52% | -0.10 51.61% |
| Revenue Q2Q % growth | 18.921M 2.20% | 21.386M 16.11% | 23.12M 35.51% | 25.262M 43.41% | 24.48M 29.38% | 25.398M 18.76% | 24.378M 5.44% | 27.336M 8.21% |
| EBITDA Q2Q % growth | -5.304M 51.75% | -5.814M 40.94% | -5.1M 30.65% | -4.947M 21.77% | N/A | N/A | N/A | 7.752M 256.70% |
| EBIT Q2Q % growth | -7.786M 32.38% | -8.024M 26.51% | -6.358M 29.36% | -5.61M 41.52% | N/A | N/A | N/A | 1.836M 132.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.38 13.64% | -0.37 | -0.01 | -2.35% |
| Q3 2025 Q2Q % growth | -0.46 25.81% | -0.29 | -0.17 | -58.80% |
| Q2 2025 Q2Q % growth | -0.38 36.67% | -0.25 | -0.13 | -50.22% |
| Q1 2025 Q2Q % growth | -0.53 27.40% | -0.39 | -0.14 | -34.96% |
| Q4 2024 Q2Q % growth | -0.44 -57.14% | -0.44 | 0.00 | 0.41% |
| Q3 2024 Q2Q % growth | -0.62 -82.35% | -0.45 | -0.17 | -39.31% |
| Q2 2024 Q2Q % growth | -0.60 -46.34% | -0.53 | -0.07 | -13.56% |
| Q1 2024 Q2Q % growth | -0.73 -97.30% | -0.48 | -0.25 | -51.24% |
| Q4 2023 Q2Q % growth | -0.28 -27.27% | -0.38 | 0.10 | 26.68% |
| Q3 2023 Q2Q % growth | -0.34 -54.55% | -0.45 | 0.11 | 24.92% |
| Q2 2023 Q2Q % growth | -0.41 -64.00% | -0.33 | -0.08 | -23.91% |
| Q1 2023 Q2Q % growth | -0.37 2.63% | -0.26 | -0.11 | -44.52% |
| Q4 2022 Q2Q % growth | -0.22 -29.41% | -0.30 | 0.08 | 26.20% |
| Q3 2022 Q2Q % growth | -0.22 15.38% | -0.35 | 0.13 | 36.47% |
| Q2 2022 Q2Q % growth | -0.25 3.85% | -0.40 | 0.15 | 37.15% |
| Q1 2022 Q2Q % growth | -0.38 20.83% | -0.39 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.17 71.67% | -0.40 | 0.23 | 57.54% |
| Q3 2021 Q2Q % growth | -0.26 63.38% | -0.39 | 0.13 | 32.92% |
| Q2 2021 Q2Q % growth | -0.26 56.67% | -0.29 | 0.03 | 11.34% |
| Q1 2021 Q2Q % growth | -0.48 32.39% | -0.31 | -0.17 | -55.57% |
| Q4 2020 Q2Q % growth | -0.60 | -0.44 | -0.16 | -35.23% |
| Q3 2020 Q2Q % growth | -0.71 | -0.39 | -0.32 | -82.82% |
| Q2 2020 Q2Q % growth | -0.60 | -0.25 | -0.35 | -140.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 17.615M -4.30% | 17.817M | -202K | -1.13% |
| Q3 2025 Q2Q % growth | 17.062M -12.71% | 18.547M | -1.485M | -8.01% |
| Q2 2025 Q2Q % growth | 18.418M 21.21% | 23.061M | -4.643M | -20.13% |
| Q1 2025 Q2Q % growth | 18.514M 66.73% | 21.565M | -3.051M | -14.15% |
| Q4 2024 Q2Q % growth | 18.406M 29.67% | 21.464M | -3.058M | -14.25% |
| Q3 2024 Q2Q % growth | 19.546M 43.25% | 19.814M | -268K | -1.35% |
| Q2 2024 Q2Q % growth | 15.195M 29.29% | 15.028M | 167K | 1.11% |
| Q1 2024 Q2Q % growth | 11.104M 5.25% | 11.268M | -164K | -1.46% |
| Q4 2023 Q2Q % growth | 14.195M 50.05% | 14.79M | -595K | -4.02% |
| Q3 2023 Q2Q % growth | 13.645M 50.11% | 13.635M | 10K | 0.07% |
| Q2 2023 Q2Q % growth | 11.753M 40.92% | 11.547M | 206K | 1.78% |
| Q1 2023 Q2Q % growth | 10.55M 39.92% | 10.538M | 12K | 0.11% |
| Q4 2022 Q2Q % growth | 9.46M 36.31% | 8.849M | 611K | 6.90% |
| Q3 2022 Q2Q % growth | 9.09M 29.49% | 7.173M | 1.917M | 26.73% |
| Q2 2022 Q2Q % growth | 8.34M -19.03% | 7.293M | 1.047M | 14.36% |
| Q1 2022 Q2Q % growth | 7.54M -14.03% | 6.913M | 627K | 9.07% |
| Q4 2021 Q2Q % growth | 6.94M 36.08% | 7.14M | -200K | -2.80% |
| Q3 2021 Q2Q % growth | 7.02M 38.74% | 6.881M | 139.335K | 2.03% |
| Q2 2021 Q2Q % growth | 10.3M 52.01% | 8.043M | 2.257M | 28.06% |
| Q1 2021 Q2Q % growth | 8.77M 76.74% | 6.883M | 1.887M | 27.42% |
| Q4 2020 Q2Q % growth | 5.1M | 5.712M | -612K | -10.71% |
| Q3 2020 Q2Q % growth | 5.06M | 4.998M | 62K | 1.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -19.74% | 0% | -20.03% |
| Revenue | -2.08% | -5.21% | -0.43% | -5.7% |